European evidence based consensus on the diagnosis and management of Crohn's disease: current management - PubMed (original) (raw)

. 2006 Mar;55 Suppl 1(Suppl 1):i16-35.

doi: 10.1136/gut.2005.081950b.

E F Stange, M Lémann, T Oresland, Y Chowers, A Forbes, G D'Haens, G Kitis, A Cortot, C Prantera, P Marteau, J-F Colombel, P Gionchetti, Y Bouhnik, E Tiret, J Kroesen, M Starlinger, N J Mortensen; European Crohn's and Colitis Organisation

Affiliations

European evidence based consensus on the diagnosis and management of Crohn's disease: current management

S P L Travis et al. Gut. 2006 Mar.

Abstract

This second section of the European Crohn's and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns treatment of active disease, maintenance of medically induced remission, and surgery. The first section on definitions and diagnosis includes the aims and methods of the consensus, as well as sections on diagnosis, pathology, and classification of Crohn's disease. The third section on special situations in Crohn's disease includes postoperative recurrence, fistulating disease, paediatrics, pregnancy, psychosomatics, extraintestinal manifestations, and alternative therapy for Crohn's disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: the authors have variously received unrestricted educational grants, consultancy fees and/or hospitality from all pharmaceutical companies in the field of inflammatory bowel disease, but no author was paid for this work nor did any company contribute to the consensus statements or text.

References

    1. Su C, Lichtenstein G R, Krok K.et al A meta‐analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease. Gastroenterology 20041261257–1269. - PubMed
    1. Hanauer S B, Strömberg U. Oral Pentasa in the treatment of active Crohn's disease: a meta‐analysis of double‐blind, placebo‐controlled trials. Clin Gastroenterol Hepatol 20042379–388. - PubMed
    1. Greenberg G R, Feagan B G, Martin F.et al Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. New Engl J Med 1994331836–841. - PubMed
    1. Otley A, Steinhart A H, Otley A. Budesonide for induction of remission in Crohn's disease. Cochrane Library. Issue 4 Chichester: Wiley, 2005 - PubMed
    1. Thomsen O O, Cortot A, Jewell D P.et al A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide‐Mesalamine Study Group. N Engl J Med 1998339370–374. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources